1. Home
  2. INBS vs ASPS Comparison

INBS vs ASPS Comparison

Compare INBS & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • ASPS
  • Stock Information
  • Founded
  • INBS 2016
  • ASPS 1999
  • Country
  • INBS United States
  • ASPS Luxembourg
  • Employees
  • INBS N/A
  • ASPS N/A
  • Industry
  • INBS Medical Specialities
  • ASPS Other Consumer Services
  • Sector
  • INBS Health Care
  • ASPS Consumer Discretionary
  • Exchange
  • INBS Nasdaq
  • ASPS Nasdaq
  • Market Cap
  • INBS 8.7M
  • ASPS 9.2M
  • IPO Year
  • INBS N/A
  • ASPS N/A
  • Fundamental
  • Price
  • INBS $1.66
  • ASPS $6.29
  • Analyst Decision
  • INBS
  • ASPS
  • Analyst Count
  • INBS 0
  • ASPS 0
  • Target Price
  • INBS N/A
  • ASPS N/A
  • AVG Volume (30 Days)
  • INBS 137.5K
  • ASPS 18.4K
  • Earning Date
  • INBS 05-13-2025
  • ASPS 07-24-2025
  • Dividend Yield
  • INBS N/A
  • ASPS N/A
  • EPS Growth
  • INBS N/A
  • ASPS N/A
  • EPS
  • INBS N/A
  • ASPS N/A
  • Revenue
  • INBS $2,936,472.00
  • ASPS $164,104,000.00
  • Revenue This Year
  • INBS $280.88
  • ASPS $38.29
  • Revenue Next Year
  • INBS $126.26
  • ASPS N/A
  • P/E Ratio
  • INBS N/A
  • ASPS N/A
  • Revenue Growth
  • INBS 3.87
  • ASPS 13.12
  • 52 Week Low
  • INBS $1.00
  • ASPS $3.46
  • 52 Week High
  • INBS $3.00
  • ASPS $16.24
  • Technical
  • Relative Strength Index (RSI)
  • INBS 67.48
  • ASPS 46.48
  • Support Level
  • INBS $1.35
  • ASPS $5.90
  • Resistance Level
  • INBS $1.68
  • ASPS $6.51
  • Average True Range (ATR)
  • INBS 0.10
  • ASPS 0.53
  • MACD
  • INBS 0.04
  • ASPS -0.02
  • Stochastic Oscillator
  • INBS 92.31
  • ASPS 52.30

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

About ASPS Altisource Portfolio Solutions S.A.

Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.

Share on Social Networks: